cas 1251580-13-8|| where to buy N-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]-2-[(pyrimidin-2-yl)amino]-1,3-thiazole-4-carboxamide

Nom du produit:N-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]-2-[(pyrimidin-2-yl)amino]-1,3-thiazole-4-carboxamide

IUPAC Name:N-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]-2-[(pyrimidin-2-yl)amino]-1,3-thiazole-4-carboxamide

: CAS：1251580-13-8; Formule moléculaire：C16H11N7OS2; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1251580-13-8 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1251580-13-8; Formule moléculaire:C16H11N7OS2; Point de fusion:-; Code SMILES:O=C(NC1=NC(=CS1)C1=CC=CN=C1)C1=CSC(NC2=NC=CC=N2)=N1; Densité:

: Numéro de catalogue:CM999506; Poids moléculaire:381.43; Point d'ébullition:; N° Mdl:; Stockage:

: Thiazoles; Thiazoles are very important functional groups in medicinal chemistry. They act as ligands on a variety of biological matrices. Thiazoles are used in a wide range of therapeutic applications, such as antibacterial, antiretroviral, antifungal, antiallergic, antihypertensive, pain treatment, and to control symptoms of schizophrenia.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.